Anzeige
Mehr »
Mittwoch, 13.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40DLB | ISIN: US81256L2034 | Ticker-Symbol:
NASDAQ
12.08.25 | 21:58
0,730 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEASTAR MEDICAL HOLDING CORPORATION Chart 1 Jahr
5-Tage-Chart
SEASTAR MEDICAL HOLDING CORPORATION 5-Tage-Chart

Aktuelle News zur SEASTAR MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrSeaStar Medical files to sell 10.92M shares of common stock for holders2
FrSeaStar Medical Holding Corp - S-1, General form for registration of securities 1
FrSeaStar Medical Holding Corp - 8-K, Current Report1
FrSeaStar Medical Holding Corp - S-8, Securities to be offered to employees in employee benefit plans2
DoSeaStar Medical to Report Second Quarter Financial Results on August 13, 20251
06.08.SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)81Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025...
► Artikel lesen
SEASTAR MEDICAL Aktie jetzt für 0€ handeln
01.08.SeaStar Medical Holding Corp - 8-K, Current Report1
31.07.SeaStar Medical raises $4.4 million in registered direct offering1
31.07.SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules1
22.07.SeaStar Medical reports positive early results from pediatric AKI therapy2
22.07.SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients293DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveillance...
► Artikel lesen
16.07.SeaStar Medical gewinnt renommierte US-Kinderklinik als Kunden für Nierentherapie2
16.07.SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry2
14.07.SeaStar Medical Holding Corp - 8-K, Current Report1
11.07.SeaStar Medical Announces $4 Mln Direct Offering With Warrants In Concurrent Private Placement1
10.07.SeaStar Medical sichert sich 4 Millionen US-Dollar über Aktienplatzierung-
10.07.SeaStar Medical raises $4 million in at-market offering1
10.07.SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules1
08.07.SeaStar Expands Program for Ill Patients-
08.07.SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)1
Weiter >>
65 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1